Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Tucidinostat|DRUG: Exemestane|DRUG: Ovarian function suppression
Sponsor: First Affiliated Hospital, Sun Yat-Sen University